Evaluation of a mobile app for cardiac patient follow-up
Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients
This study tests a mobile app to see if it helps people with atrial fibrillation and heart failure manage their health better at home.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Antwerp Academic / other |
| Locations | 1 site (Edegem, Antwerp) |
| Trial ID | NCT05951088 on ClinicalTrials.gov |
What this trial studies
This trial evaluates a mobile application designed to support patients with atrial fibrillation and heart failure in managing their conditions at home. The app provides educational resources, allows users to track health metrics, manage medications, and assess their quality of life through questionnaires. The study focuses on assessing the app's usability, long-term adherence, and patient satisfaction over time. By leveraging technology, the trial aims to enhance patient engagement and improve health outcomes.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with atrial fibrillation or heart failure who can provide informed consent.
Not a fit: Patients who cannot read or speak Dutch, have severe cognitive impairments, or do not own a smartphone or tablet may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve the management and quality of life for patients with atrial fibrillation and heart failure.
How similar studies have performed: Other studies have shown promise in using mobile health applications for chronic disease management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years, 2. Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and/or patients in whom HF is diagnosed in their medical records, 3. Patients who are capable of signing the informed consent. Exclusion Criteria: 1. Not able to speak and read Dutch, 2. Cognitive impaired (e.g. severe dementia), 3. No smartphone or tablet available.
Where this trial is running
Edegem, Antwerp
- University Hospital Antwerp — Edegem, Antwerp, Belgium (Recruiting)
Study contacts
- Principal investigator: Hein Heidbuchel — University Hospital, Antwerp
- Study coordinator: Lieselotte Knaepen
- Email: lieselotte.knaepen@uhasselt.be
- Phone: 003238213947
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.